Neutralization of IFN-γ in a mouse model has been demonstrated to abrogate rejection of transplanted fibrosarcoma cells [10] and increase aggressiveness of MCA-induced tumors arising from these transplanted cells [10]. The gene discussed is IFNG; the disease is fibrosarcoma.